Organon & Co. (OGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 574,000 | 672,000 | 599,000 | 547,000 | 675,000 |
| Receivables | 1,331,000 | 1,484,000 | 1,484,000 | 1,457,000 | 1,358,000 |
| Inventories | 1,406,000 | 1,488,000 | 1,454,000 | 1,362,000 | 1,321,000 |
| Other current assets | 1,041,000 | 1,056,000 | 1,081,000 | 1,005,000 | 994,000 |
| TOTAL | $4,352,000 | $4,700,000 | $4,618,000 | $4,371,000 | $4,348,000 |
| Non-Current Assets | |||||
| PPE Net | 1,303,000 | 1,290,000 | 1,266,000 | 1,197,000 | 1,168,000 |
| Intangibles | 5,283,000 | 6,020,000 | 6,042,000 | 6,097,000 | 6,094,000 |
| Other Non-Current Assets | 1,929,000 | 1,542,000 | 1,574,000 | 1,491,000 | 1,491,000 |
| TOTAL | $8,515,000 | $8,852,000 | $8,882,000 | $8,785,000 | $8,753,000 |
| Total Assets | $12,867,000 | $13,552,000 | $13,500,000 | $13,156,000 | $13,101,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 16,000 | 45,000 | 115,000 | 20,000 | 20,000 |
| Accounts payable and accrued liabilities | 952,000 | 1,074,000 | 1,067,000 | 1,006,000 | 1,153,000 |
| Accrued Expenses | 1,335,000 | 1,444,000 | 1,420,000 | 1,413,000 | 1,411,000 |
| Other current liabilities | 2,000 | N/A | N/A | N/A | N/A |
| TOTAL | $2,390,000 | $2,679,000 | $2,796,000 | $2,615,000 | $2,718,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,628,000 | 8,783,000 | 8,781,000 | 8,936,000 | 8,860,000 |
| Other Non-Current Liabilities | 1,040,000 | 1,122,000 | 1,121,000 | 994,000 | 977,000 |
| TOTAL | $9,725,000 | $9,967,000 | $9,971,000 | $9,999,000 | $9,911,000 |
| Total Liabilities | $12,115,000 | $12,646,000 | $12,767,000 | $12,614,000 | $12,629,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 260,316 | 259,983 | 259,966 | 259,956 | 257,950 |
| Common Shares | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 |
| Retained earnings | 1,109,000 | 1,318,000 | 1,163,000 | 1,026,000 | 1,010,000 |
| Other shareholders' equity | -527,000 | -574,000 | -572,000 | -617,000 | -649,000 |
| TOTAL | $752,000 | $906,000 | $733,000 | $542,000 | $472,000 |
| Total Liabilities And Equity | $12,867,000 | $13,552,000 | $13,500,000 | $13,156,000 | $13,101,000 |